Filtering by:
Ovarian CancerReport: Ovarian Cancer Rates Continue to Decrease
A new report from the American Cancer Society finds rates of ovarian cancer have declined by 29% between 1985 and 2014. Ovarian cancer deaths have declined 33% between 1976 and 2015.
FDA Approves Consumer Test for Certain BRCA Mutations
The US Food and Drug Administration (FDA) has approved the first direct-to-consumer tests for certain BRCA1 and BRCA2 gene mutations.
Facts & Figures 2018: Rate of Deaths From Cancer Continues Decline
The death rate from cancer in the US has declined steadily over the past 2 decades, according to annual statistics reporting from the American Cancer Society.
FDA Approves Zejula (Niraparib) for Ovarian Cancer
The US Food and Drug Administration (FDA) has approved the targeted therapy drug Zejula (niraparib) for women with some types of ovarian, fallopian tube, or peritoneal cancers.
FDA Warns Against Ovarian Cancer Screening Tests
The US Food and Drug Administration (FDA) is alerting women and their medical care providers to the risks of using tests that are marketed as screening tests for ovarian cancer.